Monitoring of soluble HLA class I size variants after liver transplantation

Human Immunology

Volumn 60, Issue 5, 1999, Pages 424-429

  Rebmann, Vera ^a   Päßler, Monika ^a   Erhard, Jochen ^a   Lange, Reinhard ^a   Eigler, Friedrich Wilhelm ^a   Grosse Wilde, Hans ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Acute allograft rejection; Cholangitis cholestasis; Liver transplantation; sHLA class I size variants; sHLA I release

Indexed keywords

HLA ANTIGEN CLASS 1;

ANTIGEN DETECTION; ARTICLE; CHOLANGITIS; CHOLESTASIS; DENSITOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HLA SYSTEM; HUMAN; LIVER TRANSPLANTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ACUTE DISEASE; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHOLANGITIS; CHOLESTASIS; DENSITOMETRY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIVER TRANSPLANTATION; MOLECULAR WEIGHT;

EID: 0344771036     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00011-7     Document Type: Article

References (31)

1. Krangel MS: Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med 163:1173, 1986.
2. Krangel MS: Two forms of HLA class I molecules in human plasma. Hum Immunol 20:155, 1987.
3. Dobbe LME, Stam NJ, Neefjes JJ, Giphart MJ: Biochemical complexity of serum HLA class I molecules. Immunogenetics 27:203, 1988.
4. Haga JA, She JX, Kao KJ: Biochemical characterization of 39-kDa class I histocompatibility antigen in plasma. J Biol Chem 266:3695, 1991.
5. Kubens BS, Päßler M, Grosse-Wilde H: Segregation study of the soluble 39-kD HLA class I heavy chain. Hum Immunol 40:247, 1994.
6. Puppo F, Picciotto A, Brenci S, Varagona G, Scudeletti M, Ghio M, Balestra V, Celle G, Indiveri F: Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response? J Clin Immunol 15:179, 1995.
7. Saririan K, Wali A, Almeida RP, Russo C: Increased serum HLA class I molecule levels in elderly human responders to influenza vaccination. Tissue Antigens 42:9, 1993.
8. Davies HffS, Pollard SG, Calne RY: Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 47:524, 1989.
9. Pollard SG, Davies HffS, Calne RY. Peroperative appearance of serum class I antigen during liver transplantation. Transplantation 49:659, 1990.
10. Tilg H, Westhoff U, Vogel W, Aulitzky WE, Herold M, Margreiter R, Huber C, Grosse-Wilde H: Soluble HLA class I serum concentrations increase with transplantrelated complications after liver transplantation. J Hepatol 14:417, 1992.
11. Puppo F, Pellicci R, Brenci S, Nocera A, Morelli N, Dardano G, Bertocchi M, Antonucci A, Ghio M, Scudeletti M, Barocci S, Valente U, Indiveri F: HLA class-1-soluble antigen serum levels in liver transplantation. A predictor marker of acute rejection. Hum Immunol 40: 166, 1994.
12. Zavazava N, Kraatz E, Gassei AM, Müller-Ruchholtz W: Plasma MHC class I expression in cardiac graft patients. Donor-specific soluble antigen in a presensitised graft patient. Transplant Proc 23:2258, 1991.
13. Zavazava N, Leimenstoll G, Müller-Ruchholtz W: Measurement of soluble MHC class I molecules in renal graft patients: a noninvasive allograft monitor. J Clin Lab Anal 4:426, 1990.
14. DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ: Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 40:191, 1994.
15. TsujiK, Kussama M, Nakatsuji T, Kato S. Biological significance of Ss (serum soluble) HLA-class I antigens in bone marrow transplantation. Tokai J Exp Clin Med 10:169, 1985.
16. Westhoff U, Doxiadis I, Beelen DW, Schaefer U, Grosse-Wilde H: Soluble HLA class I concentrations and GVHD after allogeneic marrow transplantation. Transplantation 48:890, 1989.
17. Puppo F, Brenci S, Ghio M, Bignardi D, Contini P, Bacigalupo A, Van Lint MT, Scudeletti M, Ferrone S, Indiveri F: Serum HLA class I antigen levels in allogeneic marrow transplantation: a possible marker of acute GVHD. Bone Marrow Transplant 17:753, 1996.
18. Liem LM, Koelman CA, Doxiadis I, van Houwelingen JC, Goulmy E, Claas FHJ: Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease. Bone Marrow Transplant 20:227, 1997.
19. Erhard J, Lange R, Scherer R, Eigler FW: Comparison of Histidine-Tryptophan-Ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation. Transplant Int 7:177, 1994
20. Kemnitz JP: Histopathological classification of liver allograft rejection. In: Engemann R, Hamelmann H (eds): Experimental and clinical liver transplantation. Amsterdam: Elsevier Science Publisher, 1991.
21. Neefjes JJ, Doxiadis I, Stam NJ, Beckers CJ, Ploegh HL: An analysis of class I antigens of man and other species by one-dimensional IEF and immunoblotting. Immunogenetics 23:164, 1986.
22. Westhoff U, Grosse-Wilde H: Soluble HLA class I and class II concentrations in factor VIII and PCC preparations. Vox Sang 68:73, 1995.
23. Pouletty P, Ferrone S, Amesland F, Cohen N, Westhoff U, Charron D, Shimizu RM, Grosse-Wilde H: Summary report from the first international workshop on soluble HLA antigens. Paris, August 1992. Tissue Antigens 42: 45, 1993.
24. Aulitzky WE, Grosse-Wilde H, Westhoff U, Tilg H, Aulitzky W, Gastl G, Herold M, Huber C: Enhanced serum levels of soluble HLA class I molecules are unduced by treatment with recombinant interferon-gamma (IFN-gamma). Clin Exp Immunol 86:236, 1991.
25. Maio M, Gulwani B, Langer JA, Kerbel RS, Duigou GJ, Fishe PB, Ferrone S: Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metasttic potential. Cancer Res 49:2980, 1989.
26. Hillebrand K, Moritz T, Westhoff U, Niederle N, Grosse-Wilde H: Soluble HLA class I and beta-2-microglobulin plasma concentrations during interferon treatment of chronic myelogenous leukemia. Vox Sang 67:310, 1994.
27. 2-microglobulin. J Exp Med 171: 1431, 1990.
28. 2m-free MHC class I molecules induced on activated T cells. Cell Immunol 142:103, 1992.
29. 2microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. J Biol Chem 269:6689, 1994.
30. Chakrabarti A, Matko J, Rahman NA, Barisas BG, Edidin M: Self-association of class I major histocompatibility complex molecules in liposome and cell surface membranes. Biochemistry 31:7182, 1992.
31. Haga JA, Rile WJ, Kao KJ: Effect of HLA phenotype and gender on expression of various forms of class I HLA in plasma. Hum Immunol 32:79, 1991.